精神分裂症

Lead Consultant Psychiatrist

National Psychosis Service

Director of Research and Development

South London and Maudsley NHS Foundation Trust

Reader in Psychopharmacology and Physical Health

Institute of Psychiatry, Psychology and Neuroscience

Kings College London

UK

利益声明

FG has received support or honoraria for CME, advisory work, and lectures from Lundbeck, Otsuka, and Sunovion; collaborated with a research group supported by NHS Innovations and Janssen; and has a family member with professional links to Lilly and GSK, including shares. FG is in part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London and the South London Collaboration for Leadership in Applied Health Research & Care Funding scheme, and by the Maudsley Charity and the Stanley Medical Research Institute. Any views expressed in her work are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.

Academic Clinical Fellow

Institute of Psychiatry, Psychology and Neuroscience

King's College London

UK

利益声明

TP has received honoraria for contributing to speaker meetings organised by Sunovion, Lundbeck, and Otsuka.

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:

Adrian Preda, MD

Professor of Clinical Psychiatry

Department of Psychiatry and Human Behavior

University of California, Irvine School of Medicine

Irvine

CA

Robert G. Bota, MD

Health Sciences Clinical Professor of Psychiatry

University of California

Irvine

CA

Disclosures

AP declares that he has no competing interests. RGB declares that he has no competing interests.

Section Editor, BMJ Best Practice

利益声明

AS declares that she has no competing interests.

Lead Section Editor, BMJ Best Practice

利益声明

SM works as a freelance medical journalist and editor, video editorial director and presenter, and communications trainer. In this capacity, she has been paid, and continues to be paid, by a wide range of organisations for providing these skills on a professional basis. These include: NHS organisations, including the National Institute for Health and Care Excellence, NHS Choices, NHS Kidney Care, and others; publishers and medical education companies, including the BMJ Group, the Lancet group, Medscape, and others; professional organisations, including the British Thoracic Oncology Group, the European Society for Medical Oncology, the National Confidential Enquiry into Patient Outcome and Death, and others; charities and patients’ organisations, including the Roy Castle Lung Cancer Foundation and others; pharmaceutical companies, including Bayer, Boehringer Ingelheim, Novartis, and others; and communications agencies, including Publicis, Red Healthcare and others. She has no stock options or shares in any pharmaceutical or healthcare companies; however, she invests in a personal pension, which may invest in these types of companies. She is managing director of Susan Mayor Limited, the company name under which she provides medical writing and communications services.

Lead Section Editor, BMJ Best Practice

利益声明

RW declares that she has no competing interests.

Comorbidities Editor, BMJ Best Practice

利益声明

JC declares that she has no competing interests.

Drug Editor, BMJ Best Practice

利益声明

AM declares that he has no competing interests.